Signos is a continuous glucose monitoring (“CGM”) wearable device that enhances individual metabolic health through data. The company combines the CGM device with an AI-driven app to deliver real-time glucose monitoring that translates an individual's metabolic signals into timely recommendations for eating, exercise, and better health. Signos was founded in 2018 and is based in Burlingame, California.